Christina Ma is a Partner in the Antitrust Department of Wachtell, Lipton, Rosen & Katz. Her practice focuses on analyzing competition issues arising out of mergers, acquisitions, and joint ventures and advising and representing clients before the U.S. and international antitrust authorities.  Christina has guided clients through extensive agency merger investigations, trials, and antitrust compliance matters in varied industries, including banking and financial services, consumer products, energy, pharmaceuticals, technology, and retail and wholesale operations.

Christina has been recognized for her work and accomplishments by Bloomberg Law, Best Lawyers’, Chambers, Lawdragon, MergerLinks and the New York Law Journal.

Representations by Christina include:

• Gibraltar Industries in its $1.3 billion acquisition of OmniMax International
• Electronic Arts in its $55 billion acquisition by the Saudi Arabia Public Investment Fund, Silver Lake and Affinity Partners
• Rayonier in its $8.2 billion all-stock merger of equals with PotlatchDeltic
• Teck Resources in its $69 billion merger of equals with Anglo American
• Synovus in its $17 billion all-stock combination with Pinnacle Financial Partners
• Hidden Road in its $1.25 billion acquisition by Ripple
• Core Scientific in its $9 billion proposed acquisition by CoreWeave
• Seagate Technology in its acquisition of Intevac
• Capital One in its $35 billion acquisition of Discover Financial Services
• Consol Energy in its $5.2 billion merger with Arch Resources
• Jacobs Solutions in its divestiture of its Critical Missions Solutions business in a Reverse Morris Trust transaction with Amentum
• The J.M. Smucker Co. in its $5.6 billion acquisition of Hostess Brands
• National Instruments in its $8.2 billion acquisition by Emerson
• Univar Solutions in its $8.1 billion acquisition by Apollo
• LKQ Corporation in its $2.1 billion acquisition of Uni-Select
• NuVasive in its $3.1 billion acquisition by Globus Medical
• Edgewell Personal Care in its acquisition of Billie
• Hill-Rom in its $12.4 billion acquisition by Baxter International
• Alexion Pharmaceuticals in its $39 billion acquisition by AstraZeneca

Christina is co-chair of the ABA Antitrust Law Section’s Technology Committee and Chair of the NYSBA Antitrust Law Section’s Mergers Committee. She also serves on the advisory council for Columbia Law School’s Center for Public Research and Leadership.

Christina graduated from Brown University and received her J.D. from Columbia Law School, where she was a James Kent Scholar, Essay & Review Editor for the Columbia Law Review, and the recipient of the Young B. Smith and the Valentin J.T. Wertheimer prizes.  Prior to joining the firm, Christina served as a law clerk to the Honorable Amalya L. Kearse of the United States Court of Appeals for the Second Circuit.